Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targe…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
Federal regulators have unveiled a pilot program for clinical trials that they say will reduce the time it takes to test drugs. The Food and Drug Administration program will feature real-time clinical ...
Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and ...
Clinical trials are essential for testing the effectiveness of promising new therapies to improve the lives of people with neurofibromatosis. Many people living with NF are interested in advancing ...
To accelerate Parkinson's disease (PD) research and connect eligible participants with clinical trials, the Parkinson's Foundation announced the first major milestone of its new PD Trial Navigator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results